• LAST PRICE
    1.2200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.1900/ 2
  • Ask / Lots
    1.2400/ 62
  • Open / Previous Close
    0.0000 / 1.2200
  • Day Range
    ---
  • 52 Week Range
    Low 1.1500
    High 23.6600
  • Volume
    530
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.23
TimeVolumeSPRC
09:32 ET10661.23
09:36 ET1001.2244
09:43 ET13001.22
09:45 ET76551.18
09:48 ET9091.21
09:50 ET10001.185
09:52 ET4091.2
09:54 ET1101.19
09:56 ET4001.1908
09:57 ET5001.19
09:59 ET1881.2
10:01 ET6451.2
10:03 ET6161.2
10:06 ET1001.2
10:10 ET6001.21
10:12 ET31001.24
10:14 ET30001.18
10:19 ET1001.1801
10:32 ET1001.2
10:33 ET2001.2099
10:35 ET1001.2001
10:39 ET12131.205
10:42 ET54601.21
10:44 ET10001.22
11:02 ET24001.2
11:13 ET1001.2
11:26 ET40901.21
11:36 ET3871.1912
11:47 ET2801.21
12:18 ET3501.1901
12:38 ET3681.21
12:43 ET13251.2099
01:06 ET23971.2
01:08 ET3181.2
01:10 ET30001.1918
01:14 ET8231.2091
01:24 ET10001.2
01:35 ET1001.205
01:37 ET23021.21
02:06 ET2001.201
02:09 ET1001.21
02:18 ET18251.22
02:27 ET5001.215
02:29 ET16001.2107
02:31 ET1441.22
02:33 ET3561.22
03:02 ET2001.218
03:05 ET10001.215
03:59 ET2001.22
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSPRC
Scisparc Ltd
3.2M
-1.0x
---
United StatesACAN
Americann Inc
1.6M
-5.5x
---
United StatesRXEI
RXElite Inc
120.0
0.0x
---
United StatesHYEX
Healthy Extracts Inc
5.9M
-2.3x
---
United StatesMINE
Minerco Inc
13.0K
0.0x
---
United StatesVPOR
Vapor Group Inc
27.3K
0.0x
---
As of 2024-04-23

Company Information

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Contact Information

Headquarters
20 Raul Wallenberg Street, Tower ATEL AVIV-YAFO, Israel 6971916
Phone
---
Fax
---

Executives

Chairman of the Board
Itschak Shrem
Chief Executive Officer, Director
Amitay Weiss
Chief Financial Officer
Oz Adler
Chief Technology Officer
Adi Zuloff-Shani
Director
Moshe Revach

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.2M
Revenue (TTM)
$0.00
Shares Outstanding
2.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.22
Book Value
$10.77
P/E Ratio
-1.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.